Skip to main content
NMG logo
NMG
(NYSE)
Nouveau Monde Graphite Inc.
$1.46-- (--)
Loading... - Market loading

Nouveau Monde Graphite (NMG) Income Statement

Revenue, expenses, profit margins, and earnings with annual and quarterly data.

Nouveau Monde Graphite Income Statement Analysis

Revenue, earnings, and profit margins in millions CAD

Scroll to see more
Nouveau Monde Graphite Inc. income statement - Annual data in millions CAD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Revenue & Gross Profit
Revenue0.000.000.000.000.000.000.000.00
Cost of Revenue7.9410.9125.404.271.563.140.720.49
Gross Profit-7.94-10.91-25.40-4.27-1.56-3.14-0.72-0.49
Operating Expenses
Research & Development0.000.000.000.000.000.000.000.00
Selling, General & Administrative31.8429.7422.7032.5525.127.775.074.49
Operating Expenses51.7574.2355.1050.8936.8821.025.074.72
Operating Income-59.69-85.13-55.1055.19-38.44-16.72-5.79-5.21
Other Income/Expense
Interest Income3.043.612.700.700.330.040.130.01
Interest Expense1.514.15-11.281.732.32-1.270.270.01
Other Income/Expense-46.6212.83-0.48-102.510.983.04-34.73-0.03
Income
Income Before Tax-104.78-72.89-55.58-47.31-39.49-17.98-6.06-5.24
Income Tax Expense0.400.400.400.400.401.240.782.82
Net Income-105.18-73.29-55.98-47.71-39.89-17.98-6.83-8.06
Net Income - Continuous Operations-105.18-73.29-55.98-47.71-39.89-19.22-6.83-8.06
Net Income - Discontinued Operations0.000.000.000.000.000.000.000.00
EBITDA-95.93-59.65-46.96-41.03-36.08-15.51-16.05-4.75
EBIT-103.27-68.74-55.10-55.19-37.17-16.720.000.00
Depreciation & Amortization7.349.097.684.561.100.741.080.49
Earnings Per Share
Basic EPS--1.001.00-1.00-1.00-1.00--1.00
Diluted EPS--1.001.00-1.00-1.00-1.00--1.00
Basic Shares Outstanding0.00103.1360.0955.6042.9742.9722.7215.06
Diluted Shares Outstanding0.00103.1360.0955.6042.9742.9722.7215.06

These financial metrics are calculated using income statement data. Learn how each metric works and screen stocks by them.